Efficacy and safety of nivolumab monotherapy in patients with metastatic urothelial cancer (mUC) who have received prior treatment: Results from the phase II CheckMate 275 study
Authors:
- GalskyGAGalsky
- M. RetzMRM. Retz
- A.O. Siefker-RadtkeASA.O. Siefker-Radtke
- A. BaronABA. Baron
- A. NecchiANA. Necchi
- J. BedkeJBJ. Bedke
- E.R. PlimackEPE.R. Plimack
- D. VaenaDVD. Vaena
- M.-O. GrimmMGM.-O. Grimm
- S. BracardaSBS. Bracarda
- J. Arranz ArijaJAJ. Arranz Arija
- S.K. PalSPS.K. Pal
- 13 October 2016
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 27 (suppl_6) , vi567